Xtant Medical Holdings Inc (XTNT) - Net Assets
Based on the latest financial reports, Xtant Medical Holdings Inc (XTNT) has net assets worth $50.95 Million USD as of December 2025. Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets ($94.14 Million) and total liabilities ($43.19 Million). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off. Check XTNT asset resilience ratio to evaluate the company's liquid asset resilience ratio.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | $50.95 Million |
| % of Total Assets | 54.12% |
| Annual Growth Rate | 64.01% |
| 5-Year Change | 64.99% |
| 10-Year Change | N/A |
| Growth Volatility | 12374.13 |
Xtant Medical Holdings Inc - Net Assets Trend (2008–2025)
This chart illustrates how Xtant Medical Holdings Inc's net assets have evolved over time, based on quarterly financial data. Also explore Xtant Medical Holdings Inc assets under control for the complete picture of this company's asset base.
Annual Net Assets for Xtant Medical Holdings Inc (2008–2025)
The table below shows the annual net assets of Xtant Medical Holdings Inc from 2008 to 2025. For live valuation and market cap data, see Xtant Medical Holdings Inc market capitalisation.
| Year | Net Assets | Change |
|---|---|---|
| 2025-12-31 | $50.95 Million | +18.60% |
| 2024-12-31 | $42.96 Million | -16.33% |
| 2023-12-31 | $51.35 Million | +50.27% |
| 2022-12-31 | $34.17 Million | +10.65% |
| 2021-12-31 | $30.88 Million | +112.78% |
| 2020-12-31 | $14.51 Million | +132.83% |
| 2019-12-31 | $-44.20 Million | -0.99% |
| 2018-12-31 | $-43.77 Million | +25.43% |
| 2017-12-31 | $-58.70 Million | -729.87% |
| 2016-12-31 | $-7.07 Million | -179.69% |
| 2015-12-31 | $8.88 Million | +214.17% |
| 2014-12-31 | $-7.77 Million | -102.36% |
| 2013-12-31 | $-3.84 Million | -190.78% |
| 2012-12-31 | $4.23 Million | -23.06% |
| 2011-12-31 | $5.50 Million | +988.35% |
| 2010-12-31 | $-619.24K | -113.22% |
| 2009-12-31 | $4.68 Million | +41209.18% |
| 2008-12-31 | $11.34K | -- |
Equity Component Analysis
This analysis shows how different components contribute to Xtant Medical Holdings Inc's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have decreased by 25447794400.0% over the analyzed period, potentially due to dividend distributions or operating losses.
Current Equity Component Breakdown (December 2025)
| Component | Amount | Percentage |
|---|---|---|
| Other Components | $305.44 Million | 599.45% |
| Total Equity | $50.95 Million | 100.00% |
Xtant Medical Holdings Inc Competitors by Market Cap
The table below lists competitors of Xtant Medical Holdings Inc ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
ktcs corporation
KO:058850
|
$67.23 Million |
|
Bina Puri Holdings Bhd
KLSE:5932
|
$67.26 Million |
|
Solborn Inc
KQ:035610
|
$67.27 Million |
|
OptimumBank Holdings, Inc.
NYSE MKT:OPHC
|
$67.28 Million |
|
Sypris Solutions Inc
NASDAQ:SYPR
|
$67.19 Million |
|
TECO Image Systems Co Ltd
TWO:5438
|
$67.19 Million |
|
NextSource Materials Inc
TO:NEXT
|
$67.18 Million |
|
Forian Inc
NASDAQ:FORA
|
$67.17 Million |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in Xtant Medical Holdings Inc's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2024 to 2025, total equity changed from 42,963,000 to 50,953,000, a change of 7,990,000 (18.6%).
- Net income of 4,973,000 contributed positively to equity growth.
- Share repurchases of 65,000 reduced equity.
- Other comprehensive income increased equity by 316,000.
- Other factors increased equity by 2,766,000.
Equity Change Factors (2024 to 2025)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | $4.97 Million | +9.76% |
| Share Repurchases | $65.00K | -0.13% |
| Other Comprehensive Income | $316.00K | +0.62% |
| Other Changes | $2.77 Million | +5.43% |
| Total Change | $- | 18.60% |
Book Value vs Market Value Analysis
This analysis compares Xtant Medical Holdings Inc's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 1.41x
- The company is trading above its book value, indicating the market recognizes value beyond its reported assets.
- The price-to-book ratio has decreased from 10.26x to 1.41x over the analyzed period, indicating reduced market premium.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2008-12-31 | $0.05 | $0.48 | x |
| 2009-12-31 | $19.33 | $0.48 | x |
| 2010-12-31 | $-2.10 | $0.48 | x |
| 2011-12-31 | $15.42 | $0.48 | x |
| 2012-12-31 | $10.88 | $0.48 | x |
| 2013-12-31 | $-8.82 | $0.48 | x |
| 2014-12-31 | $-14.25 | $0.48 | x |
| 2015-12-31 | $10.70 | $0.48 | x |
| 2016-12-31 | $-6.65 | $0.48 | x |
| 2017-12-31 | $-38.65 | $0.48 | x |
| 2018-12-31 | $-3.70 | $0.48 | x |
| 2019-12-31 | $-3.36 | $0.48 | x |
| 2020-12-31 | $0.51 | $0.48 | x |
| 2021-12-31 | $0.36 | $0.48 | x |
| 2022-12-31 | $0.36 | $0.48 | x |
| 2023-12-31 | $0.40 | $0.48 | x |
| 2024-12-31 | $0.32 | $0.48 | x |
| 2025-12-31 | $0.34 | $0.48 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently Xtant Medical Holdings Inc utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): 9.76%
- The company has moderate efficiency in generating returns from equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: 3.71%
- • Asset Turnover: 1.42x
- • Equity Multiplier: 1.85x
- Recent ROE (9.76%) is above the historical average (-33.63%), indicating improving capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2008 | -139.71% | -3.45% | 3.29x | 12.32x | $-16.98K |
| 2009 | -88.07% | -55.80% | 0.71x | 2.24x | $-4.59 Million |
| 2010 | 0.00% | -126.27% | 0.98x | 0.00x | $-19.41 Million |
| 2011 | -54.65% | -9.97% | 1.30x | 4.21x | $-3.56 Million |
| 2012 | -182.26% | -23.39% | 0.96x | 8.15x | $-8.14 Million |
| 2013 | 0.00% | -38.38% | 1.15x | 0.00x | $-12.31 Million |
| 2014 | 0.00% | -29.74% | 1.26x | 0.00x | $-9.73 Million |
| 2015 | -24.50% | -3.66% | 0.41x | 16.12x | $-3.06 Million |
| 2016 | 0.00% | -21.66% | 0.62x | 0.00x | $-18.79 Million |
| 2017 | 0.00% | -63.44% | 0.78x | 0.00x | $-46.54 Million |
| 2018 | 0.00% | -97.09% | 1.56x | 0.00x | $-65.72 Million |
| 2019 | 0.00% | -12.71% | 1.50x | 0.00x | $-3.80 Million |
| 2020 | -48.39% | -13.17% | 1.29x | 2.86x | $-8.47 Million |
| 2021 | -15.70% | -8.77% | 1.01x | 1.77x | $-7.94 Million |
| 2022 | -24.83% | -14.64% | 0.96x | 1.76x | $-11.90 Million |
| 2023 | 1.29% | 0.72% | 0.99x | 1.80x | $-4.47 Million |
| 2024 | -38.29% | -14.03% | 1.25x | 2.18x | $-20.75 Million |
| 2025 | 9.76% | 3.71% | 1.42x | 1.85x | $-122.30K |
Industry Comparison
This section compares Xtant Medical Holdings Inc's net assets metrics with peer companies in the Medical Devices industry.
Industry Context
- Industry: Medical Devices
- Average net assets among peers: $1,920,959,967
- Average return on equity (ROE) among peers: -107.97%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| Xtant Medical Holdings Inc (XTNT) | $50.95 Million | -139.71% | 0.85x | $67.23 Million |
| Abbott Laboratories (ABT) | $17.48 Billion | 27.92% | 1.43x | $151.99 Billion |
| Adagio Medical Holdings, Inc Common Stock (ADGM) | $-72.62 Million | 0.00% | 0.00x | $18.68 Million |
| Aethlon Medical Inc (AEMD) | $-704.50K | 0.00% | 0.00x | $2.79 Million |
| Acutus Medical Inc (AFIB) | $105.73 Million | -116.68% | 0.61x | $903.35K |
| Adapthealth Corp (AHCO) | $1.58 Billion | 5.73% | 1.84x | $1.39 Billion |
| 20/20 Biolabs, Inc. Common Stock (AIDX) | $784.36K | -284.06% | 0.72x | $10.14 Million |
| Allurion Technologies, Inc. (ALUR) | $-32.31 Million | 0.00% | 0.00x | $10.18 Million |
| Autonomix Medical, Inc. Common Stock (AMIX) | $1.96 Million | -680.21% | 0.05x | $3.99 Million |
| Artivion Inc (AORT) | $148.69 Million | 4.92% | 0.18x | $1.09 Billion |
| Apyx Medical Inc (APYX) | $412.30K | -37.38% | 7.73x | $153.68 Million |
About Xtant Medical Holdings Inc
Xtant Medical Holdings, Inc. provides regenerative medicine products and medical devices for orthopedic and neurological surgeons in the United States and internationally. It offers OsteoSponge, a natural scaffold for cellular in-growth; OsteoSelect DBM Putty, a moldable demineralized bone matrix; OsteoSelect PLUS DBM Putty to deliver handling properties and ensure patient safety through validate… Read more